*1.Please list your last name and zip code:(Required.)

Last name:

ZIP/Postal Code:

*2.What is your specialty?(Required.)

*3.How many patients with upper gastrointestinal cancer do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.Which of the following FGFR inhibitors is not FDA approved in cholangiocarcinoma?(Required.)

Pemigatinib

Erdafitinib

Infigratinib (BGJ398)

*5.Next generation sequencing is not indicated in patients with metastatic intrahepatic cholangiocarcinoma.(Required.)

True

False